News | February 18, 2023
Asahi Kasei completes construction of microcrystalline cellulose plant
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
Point-of-Care solution to facilitate clinicians in quick and effective decision making
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
The use of procalcitonin testing for sepsis management is highest in the US
Phase-III trials were conducted for safety, and immunogenicity in around 3,100 subjects, in 14 trial sites across India (supported by BIRAC)
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications.
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
The move will add new global talent to Cytel’s Strategic Consulting group
Subscribe To Our Newsletter & Stay Updated
